Bayforest Capital LTD Alkermes Plc. Transaction History
Bayforest Capital LTD
- $121 Billion
- Q1 2025
A detailed history of Bayforest Capital LTD transactions in Alkermes Plc. stock. As of the latest transaction made, Bayforest Capital LTD holds 9,270 shares of ALKS stock, worth $283,754. This represents 0.14% of its overall portfolio holdings.
Number of Shares
9,270
Previous 4,518
105.18%
Holding current value
$283,754
Previous $130 Million
26.35%
% of portfolio
0.14%
Previous 0.16%
Shares
2 transactions
Others Institutions Holding ALKS
# of Institutions
410Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$891 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$557 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$361 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$246 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$211 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.03B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...